V2X Outpaces Defense Peers Before Earnings, but Analyst Targets Lag the Rally
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
V2X, Inc. gained 8.3% in the past week, more than double the median 2.9% advance among its closest defense peers heading into today's earnings report.
Among correlated names, LHX added 7.2% on the week and GD rose 4.6%, while NOC slipped 1.8%. V2X's outperformance is the widest in the group over that window. The stock has now climbed 17.5% over the past month to close at $83.20, which puts it above the mean analyst price target of $88.27, a gap that has narrowed sharply as the shares have run. That compression matters: the Street's most recent target revision went the wrong way, with RBC Capital cutting to $81 from $88 last week while holding a Sector Perform rating, a level now below Friday's close. A prior article noted the stock at $77.17; since then it has added a further $6.
The analyst debate reflects genuine disagreement about where growth comes from next. The bull case rests on a $13.8 billion backlog, bookings coverage of around 3.1 to 3.2 times projected 2025 sales, and improving cash conversion, management reported 23% revenue growth alongside $85.6 million in adjusted EBITDA in the most recent period. The bear case centres on Kuwait: revenue from that market fell roughly 21% to around $93 million in the first quarter of 2026 and now accounts for less than 8% of total sales. Add federal budget timing risk, a net leverage ratio of 2.51 times, and the integration complexity that remains post-merger, and the neutral cluster on the Street, RBC, Morgan Stanley and Citi, has a coherent foundation even if BofA and Citizens hold higher targets of $93 and $102 respectively.
Short positioning is not a dominant feature of this setup. Short interest at 7.6% of the free float is meaningful but has declined about 10% over the past month, and availability is ample at 379%, meaning shares for borrowers remain plentiful at roughly three available for every one currently lent. Cost to borrow is 0.51%, well within normal territory. Options positioning tells a similar story: the put/call ratio at 0.147 is slightly below its 20-day average of 0.156, about 1.5 standard deviations on the call-heavy side, which points toward more interest in upside participation than downside protection ahead of the release.
Institutional ownership adds a layer worth noting. BlackRock increased its stake to 15.8% from 12.3%, a fresh Schedule 13G/A filed October 27. FMR lifted its position to 14.1% from 12.0% in August. An activist holder, AIPCF VI, appears on the 13D register but has reduced its stake to 1.2% from 7.9% since first filing in May 2025; positions on the register are as last disclosed and holders who cross below the 5% threshold may not file again.
The print will test whether V2X's backlog strength and cash generation trajectory justify a share price that has now overshot most of the Street's targets after a month-long rally.
Stocks in this article
See the live data behind this article on ORTEX.
Open VVX on ORTEX →How this article was generated
- Generated
- 3 Nov 2026, 05:43
- Data as of
- 3 Nov 2026, 04:48
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.